Scarcity in abundance? Spatial inequalities in Rheumatoid Arthritis in a health system with financial equity

BMC Rheumatology

Table 3 RA Quantifiable risk factors related to population (Colombia, 2018)

Departamento	A-S prevalence (%)	Aging index (%)	Female (%)	Smoking (%)	W. No children	Adult obesity (%)
Departamento	A-S prevalence (%)	Aging index (%)	Female (%)	Smoking (%)	(age 30–49) (%)	Adult obesity (%)
High
Nariño	0.63	38.3	49.81	5.78	8.76	16.96
Caldas	0.50	57.07	51.10	8.6	16.25	16.41
Amazonas	0.47	12.45	49.91	5.01	5.28	27.09
Córdoba	0.46	29.28	49.93	3.94	10.45	17.87
Boyacá	0.46	45.09	49.82	5.28	11.61	16.89
Risaralda	0.45	52.5	51.33	6.72	10.42	16.13
Antioquia	0.43	39	51.12	8.02	15.18	17.63
Cauca	0.41	33.29	49.36	4.25	7.75	17.87
Medium high
Cesar	0.39	19.36	50.07	4.13	6.17	17.41
Bogotá, D.C.	0.38	40.56	51.54	7.93	14.07	16.73
Quindio	0.37	63.2	50.90	6.98	11.91	18.02
Cundinamarca	0.37	36.6	50.17	6.24	9.64	17.14
Magdalena	0.36	23.13	49.43	4.71	8.27	21.5
Valle Del Cauca	0.34	40.58	51.59	6.4	14.65	22.98
Norte De Santander	0.34	29.33	50.47	5.25	7.63	17.6
Caquetá	0.33	19.43	50.01	3.2	4.78	21.62
Medium low
Sucre	0.33	29.55	49.34	5.68	10.05	16.7
Santander	0.27	40.17	50.56	5.83	11.69	15.97
Guaviare	0.27	14.7	47.96	5.55	3.85	22.84
Tolima	0.27	47.39	50.07	6.82	11.66	18.96
Bolívar	0.27	26.83	49.99	4.15	8.55	19.72
Huila	0.27	27.37	49.84	4.16	9.67	19.73
Atlántico	0.25	29.06	50.56	3.79	13.18	22.94
Putumayo	0.23	20.56	49.54	1.92	7.93	24.14
Low
Meta	0.21	26.02	50.14	6.27	6.53	23.58
Arauca	0.21	19.2	49.84	2.89	7.32	20.8
Chocó	0.19	15.92	49.83	4.13	6.15	22.8
Casanare	0.19	18.18	49.39	5.2	5.47	19.72
La Guajira	0.18	13.29	50.49	4.41	11.27	19.48
Vichada	0.12	8.14	49.50	2.92	5.59	26.87
A.San Andrés, P Y C	0.11	30.17	51.55	3.59	10.48	28.38
Vaupés	0.03	7.62	50.01	12.81	7.46	10.93
Guainía	-	8.98	48.62	7.55	3.38	21.88

Data from Ministerio de Salud y Protección Social de Colombia, Suficiencia dataset. population refers to exposed individuals, defined as individuals enrolled in mandatory public health insurance in the contributory regime. ≥ 2 refers to patients with at least two of utilizations directly related to Rheumatoid Arthritis (RA). Age-standardized prevalence calculated following the method and standard population defined in [19].

ISSN: 2520-1026